Accelerated Pharma

General Information

We are a clinical stage biopharmaceutical company focused on utilizing our genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets.

Employees: 7
Founded: 2014
Contact Information
Address 36 Church Lane, Westport, CT 06880, US
Phone Number (203) 520-3840
Web Address
View Prospectus: Accelerated Pharma
Financial Information
Market Cap $62.0mil
Revenues $0 mil (last 12 months)
Net Income $-5.8 mil (last 12 months)
IPO Profile
Symbol ACCP
Exchange NASDAQ
Shares (millions): 1.9
Price range $8.00 - $10.00
Est. $ Volume $17.0 mil
Manager / Joint Managers Rodman & Renshaw (a unit of H.C. Wainwright)/ Maxim Group
CO-Managers -
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change